The role of antibacterial therapy in atopic eczema

Bibliography

• Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90(5):525-30
   PubMedGoogle Scholar
• Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977;113(6):780-2
   PubMedGoogle Scholar
• Mempel M, Lina G, Hojka M, High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema. Eur J Clin Microbiol Infect Dis 2003;22(5):306-9
   PubMedGoogle Scholar
• Breuer K, S HA, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147(1):55-61
   PubMedGoogle Scholar
• Hoeger PH, Lenz W, Boutonnier A, Fournier JM. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992;165(6):1064-8
   PubMedGoogle Scholar
• Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001;108(2):269-74
   PubMedGoogle Scholar
• Kisich KO, Carspecken CW, Fieve S, Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J Allergy Clin Immunol 2008;122(1):62-8
   PubMedGoogle Scholar
• Mrabet-Dahbi S, Dalpke AH, Niebuhr M, The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008;121(4):1013-19
   PubMedGoogle Scholar
• Bunikowski R, Mielke ME, Skarabis H, Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105(4):814-19
   PubMedGoogle Scholar
• Bieber T. Atopic dermatitis. N Engl J Med 2008;358(14):1483-94
   PubMedGoogle Scholar
• Mempel M, Schnopp C. Die Bedeutung von Staphylococcus aureus für das atopische Ekzem. Allergo J 2006;15:553-8
   Google Scholar
• Hayakawa K, Hirahara K, Fukuda T, Risk factors for severe impetiginized atopic dermatitis in Japan and assessment of its microbiological features. Clin Exp Dermatol 2009;34(5):e63-5
   PubMedGoogle Scholar
• Pournaras CC, Lubbe J, Saurat JH. Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506). J Invest Dermatol 2001;116(3):480-1
   PubMedGoogle Scholar
• Stalder JF, Fleury M, Sourisse M, Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994;131(4):536-40
   PubMedGoogle Scholar
• Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008(3):CD003871
   PubMedGoogle Scholar
• Hoeger PH, Ganschow R, Finger G. Staphylococcal septicemia in children with atopic dermatitis. Pediatr Dermatol 2000;17(2):111-14
   PubMedGoogle Scholar
• Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Curr Ther Res 1992;52(5):671-6
   Google Scholar
• Ewing CI, Ashcroft C, Gibbs AC, Flucloxacillin in the treatment of atopic dermatitis. Br J Dermatol 1998;138(6):1022-9
   PubMedGoogle Scholar
• Boguniewicz M, Sampson H, Leung SB, Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol 2001;108(4):651-2
   PubMed Web of Science ®Google Scholar
• Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119(2):189-98
   PubMedGoogle Scholar
• Gong JQ, Lin L, Lin T, Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006;155(4):680-7
   PubMedGoogle Scholar
• Ramsay CA, Savoie JM, Gilbert M, The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. JEADV 1996;7(Suppl 1):S15-22
   Google Scholar
• Korting HC, Zienicke H, Braun-Falco O, Modern topical glucocorticoids and anti-infectives for superinfected atopic eczema: do prednicarbate and didecyldimethylammoniumchloride form a rational combination? Infection 1994;22(6):390-4
   PubMedGoogle Scholar
• Schuttelaar ML, Coenraads PJ. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis. J Eur Acad Dermatol Venereol 2008;22(9):1076-82
   PubMedGoogle Scholar
• Yang LP, Keam SJ. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. Drugs 2008;68(6):855-73
   PubMedGoogle Scholar
• Gloor M, Becker A, Wasik B, Kniehl E. Triclosan, a topical dermatologic agent. In vitro- and in vivo studies on the effectiveness of a new preparation in the New German Formulary. Hautarzt 2002;53(11):724-9
   PubMedGoogle Scholar
• Moss T, Howes D, Williams FM. Percutaneous penetration and dermal metabolism of triclosan (2,4, 4′-trichloro-2′-hydroxydiphenyl ether). Food Chem Toxicol 2000;38(4):361-70
   PubMedGoogle Scholar
• Allmyr M, Adolfsson-Erici M, McLachlan MS, Sandborgh-Englund G. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 2006;372(1):87-93
   PubMedGoogle Scholar
• Latch DE, Packer JL, Stender BL, Aqueous photochemistry of triclosan: formation of 2,4-dichlorophenol, 2,8-dichlorodibenzo-p-dioxin, and oligomerization products. Environ Toxicol Chem 2005;24(3):517-25
   PubMedGoogle Scholar
• Delorenzo ME, Keller JM, Arthur CD, Toxicity of the antimicrobial compound triclosan and formation of the metabolite methyl-triclosan in estuarine systems. Environ Toxicol 2008;23(2):224-32
   PubMedGoogle Scholar
• Tan WP, Suresh S, Tey HL, A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis. Clin Exp Dermatol 2009. [Epub 19 Oct]
   Google Scholar
• Breneman DL, Hanifin JM, Berge CA, The effect of antibacterial soap with 1.5% triclocarban on Staphylococcus aureus in patients with atopic dermatitis. Cutis 2000;66(4):296-300
   PubMedGoogle Scholar
• Stalder JF, Fleury M, Sourisse M, Comparative effects of two topical antiseptics (chlorhexidine vs KMn04) on bacterial skin flora in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:132-4
   PubMedGoogle Scholar
• Jee R, Nel L, Gnanakumaran G, Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 2009;103(4):614-15
   PubMedGoogle Scholar
• Nagendran V, Wicking J, Ekbote A, IgE-mediated chlorhexidine allergy: a new occupational hazard? Occup Med (Lond) 2009;59(4):270-2
   PubMedGoogle Scholar
• Garvey LH, Kroigaard M, Poulsen LK, IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 2007;120(2):409-15
   PubMedGoogle Scholar
• Huang JT, Abrams M, Tlougan B, Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009;123(5):e808-14
   PubMedGoogle Scholar
• Sugimoto K, Ishikawa N, Terano T, The importance of bacterial superantigens produced by Staphylococcus aureus in the treatment of atopic dermatitis using povidone-iodine. Dermatology 2006;212(Suppl 1):26-34
   PubMedGoogle Scholar
• Sugimoto K, Kuroki H, Kanazawa M, New successful treatment with disinfectant for atopic dermatitis. Dermatology 1997;195(Suppl 2):62-8
   PubMedGoogle Scholar
• Akiyama H, Tada J, Toi J, Changes in Staphylococcus aureus density and lesion severity after topical application of povidone-iodine in cases of atopic dermatitis. J Dermatol Sci 1997;16(1):23-30
   PubMedGoogle Scholar
• Steen M. Review of the use of povidone-iodine (PVP-I) in the treatment of burns. Postgrad Med J 1993;69(Suppl 3):S84-92
   PubMedGoogle Scholar
• Wilson JR, Mills JG, Prather ID, Dimitrijevich SD. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005;18(7):373-8
   PubMedGoogle Scholar
• Nobukuni K, Hayakawa N, Namba R, The influence of long-term treatment with povidone-iodine on thyroid function. Dermatology 1997;195(Suppl 2):69-72
   PubMedGoogle Scholar
• Jappe U, Schnuch A, Uter W. Frequency of sensitization to antimicrobials in patients with atopic eczema compared with nonatopic individuals: analysis of multicentre surveillance data, 1995-1999. Br J Dermatol 2003;149(1):87-93
   PubMedGoogle Scholar
• Juenger M, Ladwig A, Staecker S, Efficacy and safety of silver textile in the treatment of atopic dermatitis (AD). Curr Med Res Opin 2006;22(4):739-50
   PubMedGoogle Scholar
• Gauger A, Mempel M, Schekatz A, Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 2003;207(1):15-21
   PubMedGoogle Scholar
• Gauger A. Silver-coated textiles in the therapy of atopic eczema. Curr Probl Dermatol 2006;33:152-64
   PubMedGoogle Scholar
• Birla SS, Tiwari VV, Gade AK, Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol 2009;48(2):173-9
   PubMedGoogle Scholar
• Koller DY, Halmerbauer G, Bock A, Engstler G. Action of a silk fabric treated with AEGIS in children with atopic dermatitis: a 3-month trial. Pediatr Allergy Immunol 2007;18(4):335-8
   PubMedGoogle Scholar
• Stinco G, Piccirillo F, Valent F. A randomized double-blind study to investigate the clinical efficacy of adding a non-migrating antimicrobial to a special silk fabric in the treatment of atopic dermatitis. Dermatology 2008;217(3):191-5
   PubMedGoogle Scholar
• Ricci G, Patrizi A, Mandrioli P, Evaluation of the antibacterial activity of a special silk textile in the treatment of atopic dermatitis. Dermatology 2006;213(3):224-7
   PubMedGoogle Scholar
• Boguniewicz M, Leung DYM. Pathophysiologic mechanisms in atopic dermatitis. Semin Cutan Med Surg 2001;20:217-25
   PubMed Web of Science ®Google Scholar
• Harper J. Double-blind comparison of an antiseptic oil-based bath additive (Oilatum Plus) with regular Oilatum (Oilatum Emollient) for the treatment of atopic eczema. The bacteriology of eczema. The Royal Society of Medicine Press Ltd., London; 1995
   Google Scholar
• Holland KT, Bojar RA, Cunliffe WJ, A comparison of the effect of treatment of atopic eczema with and without antimicrobial compounds. The bacteriology of eczema. The Royal Society of Medicine Press Ltd., London; 1995
   Google Scholar